miR-141 and miR-200a, revelation of new possible players in modulation of Th17/Treg differentiation and pathogenesis of multiple sclerosis

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Naghavian, Reza ^a,b   Ghaedi, Kamran ^a,b,c   Kiani Esfahani, Abbas ^b   Ganjalikhani Hakemi, Mazdak ^c   Etemadifar, Masoud ^c   Nasr Esfahani, Mohammad Hossein ^b  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^c AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; JANUS KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 141; MICRORNA 200A; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; INTERLEUKIN 17; MICRORNA; MIRN141 MICRORNA, HUMAN; MIRN200 MICRORNA, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MULTIPLE SCLEROSIS; PATHOGENESIS; REGULATORY T LYMPHOCYTE; TH17 CELL; UPREGULATION; CELL DIFFERENTIATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY; REMISSION; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-17; LYMPHOCYTE COUNT; MICRORNAS; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REMISSION INDUCTION; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; UP-REGULATION;

EID: 84929104273     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124555     Document Type: Article

References (35)

1. Soldan SS, Wu G, Markowitz C, Kolson DL. Multiple sclerosis and other demyelinating diseases. Neuroimmune Pharmacology: Springer. 2008; pp. 239-255.
2. Etemadifar M, Abtahi S-H, Akbari M, Murray RT, Ramagopalan SV, Fereidan-Esfahani M. Multiple sclerosis in Isfahan, Iran: an update. Multiple Sclerosis Journal. 2013; 1352458513516531.
3. Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmunity reviews. 2010; 9: A387-A394. doi: 10.1016/j.autrev.2009.11.010 PMID: 19932200
4. McFarland HF, Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nature immunology. 2007; 8: 913-919. PMID: 17712344
5. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annual review of immunology. 2010; 28: 445. doi: 10.1146/annurev-immunol-030409-101212 PMID: 20192806
6. Codarri L, Gyülvészi G, Tosevski V, Hesske L, Fontana A, Magnenat L, et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nature immunology. 2011; 12: 560-567. doi: 10.1038/ni.2027 PMID: 21516112
7. Koenen HJ, Smeets RL, Vink PM, Van Rijssen E, Boots AM, Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood. 2008; 112: 2340-2352. doi: 10.1182/ blood-2008-01-133967 PMID: 18617638
8. Zhu J, Paul WE. Peripheral CD4+ T - cell differentiation regulated by networks of cytokines and transcription factors. Immunological reviews. 2010; 238: 247-262. doi: 10.1111/j.1600-065X.2010.00951.x PMID: 20969597
9. Hakemi MG, Ghaedi K, Andalib A, Hosseini M, Rezaei A. Optimization of human Th17 cell differentiation in vitro: evaluating different polarizing factors. In Vitro Cellular & Developmental Biology-Animal. 2011; 47: 581-592.
10. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. The American journal of pathology. 2008; 172: 146-155. PMID: 18156204
11. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136: 215-233. doi: 10.1016/j.cell.2009.01.002 PMID: 19167326
12. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nature immunology. 2008; 9: 839-845. doi: 10.1038/ni.f.209 PMID: 18645592
13. Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, Arreola A, et al. Identifying mRNA targets of micro-RNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC systems biology. 2010; 4: 51. doi: 10.1186/1752-0509-4-51 PMID: 20420713
14. Honardoost MA, Kiani-Esfahani A, Ghaedi K, Etemadifar M, Salehi M. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing - remitting multiple sclerosis. Gene. 2014; 544: 128-133. doi: 10.1016/j.gene.2014.04.069 PMID: 24792898
15. Zibert JR, Løvendorf MB, Litman T, Olsen J, Kaczkowski B, Skov L. MicroRNAs and potential target interactions in psoriasis. Journal of dermatological science. 2010; 58: 177-185. doi: 10.1016/j.jdermsci.2010.03.004 PMID: 20417062
16. Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, et al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus. 2011; 20: 493-500. doi: 10.1177/0961203310389841 PMID: 21372198
17. Pekow JR, Kwon JH. MicroRNAs in inflammatory bowel disease. Inflammatory bowel diseases. 2012; 18: 187-193. doi: 10.1002/ibd.21691 PMID: 21425211
18. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk - database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. Journal of biomedical informatics. 2011; 44: 839-847. doi: 10.1016/j.jbi.2011.05.002 PMID: 21605702
19. Hsu S-D, Lin F-M, Wu W-Y, Liang C, Huang W-C, Chan W-L, et al. miRTarBase: a database curates experimentally validated microRNA - target interactions. Nucleic acids research. 2011; 39: D163-D169. doi: 10.1093/nar/gkq1107 PMID: 21071411
20. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, et al. DIANA miRPath v. 2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic acids research. 2012; 40: W498-W504. doi: 10.1093/nar/gks494 PMID: 22649059
21. Da Wei Huang BTS, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2008; 4: 44-57.
22. Fenoglio C, Cantoni C, De Riz M, Ridolfi E, Cortini F, Serpente M, et al. Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis. Neuroscience letters. 2011; 504: 9-12. doi: 10.1016/j.neulet.2011.08.021 PMID: 21875645
23. Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nature immunology. 2011; 12: 295-303. doi: 10.1038/ni.2005 PMID: 21358638
24. Edwards L, Sharrack B, Ismail A, Tumani H, Constantinescu C. Central inflammation versus peripheral regulation in multiple sclerosis. Journal of neurology. 2011; 258: 1518-1527. doi: 10.1007/s00415-011-5973-5 PMID: 21547381
25. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441: 235-238. PMID: 16648838
26. Sievers C, Meira M, Hoffmann F, Fontoura P, Kappos L, Lindberg RL. Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clinical immunology. 2012; 144: 70-79. doi: 10.1016/j.clim.2012.04.002 PMID: 22659298
27. Iborra M, Bernuzzi F, Invernizzi P, Danese S. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmunity Reviews. 2012; 11: 305-314. doi: 10.1016/j.autrev.2010.07.002 PMID: 20627134
28. Olaru AV, Selaru FM, Mori Y, Vazquez C, David S, Paun B, et al. Dynamic changes in the expression of MicroRNA - 31 during inflammatory bowel disease-associated neoplastic transformation. Inflammatory bowel diseases. 2011; 17: 221-231. doi: 10.1002/ibd.21359 PMID: 20848542
29. Liu X, He F, Pang R, Zhao D, Qiu W, Shan K, et al. IL-17-induced MiR-873 attributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin editing enzyme. Journal of Biological Chemistry: jbc. 2014; M114. 577429.
30. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annual review of immunology. 2009; 27: 485-517. doi: 10.1146/annurev.immunol.021908.132710 PMID: 19132915
31. Jetten AM. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nuclear receptor signaling. 2009; 7: e003. doi: 10.1621/nrs.07003 PMID: 19381306
32. Peters A, Lee Y, Kuchroo VK. The many faces of Th17 cells. Current opinion in immunology. 2011; 23: 702-706. doi: 10.1016/j.coi.2011.08.007 PMID: 21899997
33. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. nature immunology. 2003; 4.
34. Jadidi-Niaragh F, Mirshafiey A. The deviated balance between regulatory T cell and Th17 in autoimmunity. Immunopharmacology and immunotoxicology. 2012; 34: 727-739. doi: 10.3109/08923973.2011.619987 PMID: 22316060
35. Kim JS, Sklarz T, Banks LB, Gohil M, Waickman AT, Skuli N, et al. Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways. Nature immunology. 2013; 14: 611-618. doi: 10.1038/ni.2607 PMID: 23644504